Utilizing natural products as new E3 ligase ligands for targeted protein degradation.
10.1016/S1875-5364(23)60500-X
- Author:
Yanan GONG
1
;
Saiqi WANG
1
;
Xiao-Bing CHEN
2
;
Bin YU
3
,
4
Author Information
1. Department of Oncology, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer and Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou 450008, China.
2. Department of Oncology, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer and Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou 450008, China. Electronic address: zlyychenxb0807@zzu.edu.cn.
3. College of Chemistry, Zhengzhou University, Zhengzhou 450001, China
4. Pingyuan Laboratory, State Key Laboratory of Antiviral Drugs, Henan Normal University, Xinxiang 453007, China. Electronic address: yubin@zzu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Ubiquitin-Protein Ligases/metabolism*;
Proteolysis;
Biological Products;
Ligands
- From:
Chinese Journal of Natural Medicines (English Ed.)
2023;21(12):881-883
- CountryChina
- Language:English